Drug Trial Radar · NCT04725994
Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
87
Actual
Start
Jun 28, 2021
Primary completion
Jul 31, 2026
Study completion Mar 31, 2027
Sponsor
- Lead sponsor
- Idience Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 27, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, Phase 1b/2a study to evaluate the safety and tolerability of IDX-1197 and determine the MTD and RP2D in combination with XELOX or irinotecan in patients with advanced gastric cancer.
Conditions
- Gastric Cancer
Interventions
IDX-1197+XELOXDrug
The dose levels will be escalated following a 3+3 dose escalation scheme.
IDX-1197+IrinotecanDrug
The dose levels will be escalated following a 3+3 dose escalation scheme.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Time frame: through study completion (Up to 12 months)
- Dose Limiting Toxicities (DLTs)Time frame: during the first 21-day cycle for Group 1 and through first 2 cycles (14 days each) for Group 2
Locations
17 sites in 3 countries. Site status is shown where the registry gives one.
USC Norris Comp. Cancer Ctr Hospital
Los Angeles, California
Hematology Oncology Clinic Baton Rouge / Sarah Cannon
Baton Rouge, Louisiana
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts
Astera Cancer Care
East Brunswick, New Jersey
Beijing Cancer Hospital
Beijing, China
The Sixth Affiliated Hospital of Sun Yat-Sen University
Guangzhou, China
Shanghai East Hospital
Shanghai, China
Dong-A University Hospital
Busan, South Korea
Seoul National University Bundang Hospital
Seongnam, South Korea
Korea University Anam Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.